Reduction of C-reactive protein and the use of anti-hypertensives

References

• Agabiti RoseiEMorelliPRizzoniDEffects of nifedipine GITS 20 mg or enalapril 20 mg on blood pressure and inflammatory markers in patients with mild-moderate hypertensionBlood Press2005b11422
   Google Scholar
• Agabiti RoseiERizzoniDMuiesanMLCENTRO (CandEsartaN on aTherosclerotic Risk factOrs) study investigatorsEffects on candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin dependent diabetes mellitusJ Hypertens2005a2343544
   PubMed Web of Science ®Google Scholar
• AlbertMADanielsonERifaiNRidkerPMEffect of statin therapy on C-reactive protein levels: the pravastatin Inflammation/CRP Evaluation (PRINCE), a randomized trial and cohort studyJ Am Med Assoc20012866470
   PubMed Web of Science ®Google Scholar
• AndersenSSchalkwijkCGStehouwerCDParvingHHAngiotensin II blockade is associated with decreased leukocyte adhesion molecule levels in diabetic nephropathyDiabetes Care2000231031210895868
   PubMed Web of Science ®Google Scholar
• ArnandISLatiniRFloreaVGC-reactive protein in heart failure prognostic value and the effect of valsartanCirculation200511214283416129801
   PubMedGoogle Scholar
• BarzilayJIPetersonDCushmanMThe relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: the cardiovascular health studyAm J Kidney Dis200444253415211434
   PubMed Web of Science ®Google Scholar
• BlakeJGRidkerPMNovel clinical markers of vascular wall inflammationCirc Res2001897637111679405
   PubMed Web of Science ®Google Scholar
• BlakeGJRifaiNBuringJERidkerPMBlood pressure, C-reactive protein, and risk of future cardiovascular eventsCirculation20031082993914638538
   PubMed Web of Science ®Google Scholar
• BrullDJSandersJRumleyAImpact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 releaseHeart200287252511847165
   PubMed Web of Science ®Google Scholar
• ChaeCULeeRTRifaiNRidkerPMBlood pressure and inflammation in apparently healthy menHypertension20013839940311566912
   PubMed Web of Science ®Google Scholar
• ChobanianAVBakrisGLBlackHRNational High Blood Pressure Education Program Coordinating CommitteeSeventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: The JNC 7 ReportHypertension20034212065214656957
   PubMed Web of Science ®Google Scholar
• ChrysohoouCPitsavosCPanagiotakosDBAssociation between prehypertension status and inflammatory markers related to atherosclerotic disease: the ATTICA StudyAm J Hypertens2004175687315233975
   PubMed Web of Science ®Google Scholar
• De CiuceisCAmiriFBrassardPReduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injuryArterioscler Thromb Vasc Biol20052521061316100037
   PubMed Web of Science ®Google Scholar
• DevarajSXuDJJialalIC-Reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implication for the metabolic syndrome and atherothrombosisCirculation200310739840412551862
   PubMed Web of Science ®Google Scholar
• EngstromGJanzonLBerglundGBlood pressure increase and incidence of hypertension in relation to inflammation-sensitive plasma proteinArterioscler Thromb Vasc Biol2002222054812482834
   PubMed Web of Science ®Google Scholar
• EspositoKMarfellaRCiotolaMEffect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trialJ Am Med Assoc200429214406
   PubMed Web of Science ®Google Scholar
• FiedelBAGewurzHEffects of C-reactive protein on platelet function, II: inhibition by CRP of platelet reactivities stimulated by poly-L-lysine, ADP, epinephrine, and collagenJ Immunol197611710738977942
   PubMed Web of Science ®Google Scholar
• FliserDBuchholzKHallerHAntiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammationCirculation20041101103715313950
   PubMed Web of Science ®Google Scholar
• GalisZSSukhovaGKLarkMWIncreased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaquesJ Clin Invest1994942494503
   Web of Science ®Google Scholar
• GasicSWagnerOFFaschingPFosinopril decreases levels of soluble vascular cell adhesion molecule-1 in borderline hypertensive type II diabetic patients with microalbuminuriaAm J Hypertens1999122172210090351
   PubMed Web of Science ®Google Scholar
• GriendlingKKSorescuDLassegueBUshio-FukaiMModulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiologyArterioscler Thromb Vasc Biol20002021758311031201
   PubMed Web of Science ®Google Scholar
• GubaMSteinbauerMBuchnerMDifferential effect of short term ace- and AT1 –receptor inhibition on postischemic injury and leukocyte adherence in vivo and in vitroShock200013190610718375
   PubMed Web of Science ®Google Scholar
• HattoriYMatsumuraMKasaiKVascular smooth muscle cell activation by C-reactive proteinCardiovasc Res2003581869512667961
   PubMed Web of Science ®Google Scholar
• Hernandez-PresaMBustosCOrtegoMAngiotensin convertine enzyme inhibition prevents arterial nuclear factor kappa B activation monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosisCirculation1997951532419118522
   PubMed Web of Science ®Google Scholar
• HeuertzRMWebsterRORole of C-reactive protein in acute lung injuryMol Med Today19973539459449125
   PubMedGoogle Scholar
• JilmaBLi-Saw-HeeFLWagnerOFEffects of enalapril and losartan on circulating adhesion molecules and monocyte chemotactic protein-1Clin Sci (Lond)2002103131612149103
   PubMed Web of Science ®Google Scholar
• JoyntKEGattisWAHasselbladVEffect of angiotensin converting enzyme inhibitors, beta blockers statins, and aspirin on C-reactive protein levels in outpatients with heart failureAm J Cardiol200493783515019895
   PubMed Web of Science ®Google Scholar
• JungOMarklundSLGeigerHExtracellular superoxide dismutase is a major determinant of nitric oxide bioavailability: in vivo and ex vivo evidence from ecSOD-deficient miceCirc Res200393622912933702
   PubMed Web of Science ®Google Scholar
• KalininaNAgrotisATararakECytochrome b558-dependent NAD(P)H oxidase-phox units in smooth muscle and macrophages of atherosclerotic lesionsArterioscler Thromb Vasc Biol20022220374312482831
   PubMed Web of Science ®Google Scholar
• KhreissTJozsefLHossainSLoss of pentameric symmetry of C-reactive protein is associated with delayed apoptosis of human neutrophilsJ Biol Chem2002277407758112198121
   PubMed Web of Science ®Google Scholar
• KhreissTJozsefLPotempaLAFilepJGConformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cellsCirculation2004a10920162215051635
   PubMed Web of Science ®Google Scholar
• KhreissTJozsefLPotempaLAFilepJGOpposing effects of C-reactive protein isoforms on shear-induced neutrophil-platelet adhesion and neutrophil aggregation in whole bloodCirculation2004b11027132015492312
   PubMed Web of Science ®Google Scholar
• KranzhoferRSchmidtJPfeifferCAAngiotensin induces inflammatory activation of human vascular smooth muscle cellsArterioscler Thromb Vasc Biol1999191623162910397679
   PubMed Web of Science ®Google Scholar
• KohKKAhnJYHanSHPleiotropic effects of angiotensin II receptor blocker in hypertensive patientsJ Am Coll Cardiol20034290591012957441
   PubMed Web of Science ®Google Scholar
• KohKKHanSHChungWJComparison of effect of losartan, irbesartan, and candesartan, on flow-mediated brachial artery dilation and on inflammatory and thrombolytic markers in patients with systemic hypertensionAm J Cardiol20049314323515165934
   PubMed Web of Science ®Google Scholar
• KohKKHanSHQuonMJAhnJYShinEKBeneficial effect of fenofibrate to improve endothelial dysfunction and raise adiponectin levels in patients with primary hypertriglyceridemiaDiabetes Care2005a2814192415920062
   PubMed Web of Science ®Google Scholar
• KohKKHanSHQuonMJVascular and metabolic effect of combined therapy with ramipril and simvastatin in patients with type 2 diabetesHypertension2005b4510889315883229
   PubMed Web of Science ®Google Scholar
• KulloIJSewardJBBaileyKRC-reactive protein is related to arterial wave reflection and stiffness in asymptomatic subjects from the communityAm J Hypertens2005181123916109328
   PubMed Web of Science ®Google Scholar
• LassegueBClepmpusRENAD(P)H oxidase: specific features, expression and regulationAm J Physiol Regul Integr Comp Physiol2003285R277R9712855411
   PubMed Web of Science ®Google Scholar
• LiuJYangFYangX-PNAD(P)H oxidase mediates angiotensin II-induced vascular macrophage infiltration and medial hypertrophyArterioscler Thromb Vasc Biol2003237768212637340
   PubMed Web of Science ®Google Scholar
• LiuzzoGBIasucciLMGallimoreJRThe prognostic value of C-reactive protein and serum amyloid A protein in severe unstable anginaN Engl J Med1994331417247880233
   PubMed Web of Science ®Google Scholar
• MiyazawaKKiyonoSInoueKModulation of stimulus-dependent human platelet activation by C-reactive protein modified with active oxygen speciesJ Immunol198814157043385211
   PubMed Web of Science ®Google Scholar
• NiskanenLLaaksonenDENyyssonenKInflammation, abdominal obesity, and smoking as predictors of hypertensionHypertension2004448596515492131
   PubMed Web of Science ®Google Scholar
• NissenSETuzcuEMSchoenhagenPStatin therapy, LDL cholesterol, C-reactive protein, and coronary artery diseaseN Engl J Med2005352293815635110
   PubMed Web of Science ®Google Scholar
• ObisesanTOLeeuwemburghCPhillipsTC-Reactive protein genotypes affect baseline, but not exercise training-induced changes, in C-reactive protein levelsArterioscler Thromb Vasc Biol2004241874915271790
   PubMed Web of Science ®Google Scholar
• PalmasWMaSPsatyBAntihypertensive medications and C-reactive protein in the multi-ethnic study of atherosclerosisAm J Hypertens2007202334117324732
   PubMed Web of Science ®Google Scholar
• PasceriVWillersonJTYehETDirect proinflammatory effect of C-Reactive protein on human endothelial cellsCirculation20001022165811056086
   PubMed Web of Science ®Google Scholar
• PastoreLTessitoreAMartinotttiSAngiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increase soluble ICAM-1 release in vivoCirculation199910016465210517737
   PubMed Web of Science ®Google Scholar
• PepysMBHirschfieldGMC-reactive protein: a critical updateJ Clin Invest200311118051212813013
   PubMed Web of Science ®Google Scholar
• PotempaLASiegelNJFiedelBAExpression, detection and assay of neoantigen (neo-CRP) associated with a free C-reactive protein subunitMol Immunol198724531412443837
   PubMed Web of Science ®Google Scholar
• PueyoMEGonzalezWNicolettiAAngiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stressArterioscler Thromb Vasc Biol2000206455110712386
   PubMed Web of Science ®Google Scholar
• QamiraniERenYKuoLHeinWC-reactive protein inhibits endothelin-dependent NO-mediated dilation in coronary arterioles by activating p38 kinase and NAD(P)H oxidaseArterioscler Thromb Vasc Biol200525995100115718491
   PubMed Web of Science ®Google Scholar
• RajagopalanSBrookRMehtaRHEffect of losartan in aging related endothelial impairmentAm J Cardiol2002895626611867042
   PubMed Web of Science ®Google Scholar
• RajagopalanSKurzSMunzelTAngiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor toneJ Clin Invest1996971916238621776
   PubMed Web of Science ®Google Scholar
• RidkerPMBuringJEShihJProspective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy womenCirculation19989873139727541
   PubMed Web of Science ®Google Scholar
• RidkerPMCannonCPMorrowDC-reactive protein levels and outcomes after statin therapyN Engl J Med200535220815635109
   PubMed Web of Science ®Google Scholar
• RidkerPMCushmanMStampferMJInflammation, aspirin and the risk of cardiovascular disease in apparently healthy menN Engl J Med199733697369077376
   PubMed Web of Science ®Google Scholar
• RidkerPMDanielsonERifaiNGlynnRJfor the Val-MARC InvestigatorsValsartan, blood pressure reduction, and C-reactive protein. Primary report of the Val-MARC trialHypertension200648737916714425
   PubMed Web of Science ®Google Scholar
• SardoMACastaldoMCinquegraniMEffects of AT1 receptor antagonist losartan on sICAM-1 and TNF-alpha levels in uncomplicated hypertensive –patientsAngiology20045519520315026875
   PubMed Web of Science ®Google Scholar
• SavoiaCSchiffrinELInflammation in hypertensionCurr Opin Nephrol Hypertens20062152816481882
   PubMedGoogle Scholar
• SavoiaCSchiffrinELVascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventionsClin Sci (Lond)20071123758417324119
   PubMed Web of Science ®Google Scholar
• SchiefferBBunterCWitteJComparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery diseaseJ Am Coll Cardiol200444362815261932
   PubMed Web of Science ®Google Scholar
• SchiefferBLuchtefeldMBraunSRole of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine inductionCirc Res200087119520111110778
   PubMed Web of Science ®Google Scholar
• SchiffrinELTouyzRMInflammation and vascular hypertrophy induced by angiotensin II: role of NADPH oxidase-derived reactive oxygen species independently of blood pressure elevation?Arterioscler Thromb Vasc Biol2003a23707912740221
   PubMed Web of Science ®Google Scholar
• SchiffrinELTouyzRMMultiple actions of angiotensin II in hypertension: benefits of AT1 receptor blockadeJ Am Coll Cardiol2003b429111312957442
   PubMed Web of Science ®Google Scholar
• SchiffrinELTouyzRMFrom bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertensionAm J Physiol Heart Circ Physiol2004287H435H–4615277186
   PubMed Web of Science ®Google Scholar
• SessoHDBuringJERifaiNC-reactive protein and the risk of developing hypertensionJ Am Med Assoc2003290294551
   PubMed Web of Science ®Google Scholar
• SmithGDLawlorDAHarbordRAssociation of C-reactive protein with blood pressure and hypertension. Life course confounding and Mendelian randomization tests of causalityArterioscler Thromb Vasc Biol2005251051615731495
   PubMed Web of Science ®Google Scholar
• StrandbergTEVanhanenHTikkanenMJEffects of statins on C-reactive protein in patients with coronary artery diseaseLancet19993531181910023901
   PubMed Web of Science ®Google Scholar
• TakedaTOshidaSNishinoMRelationship between effects of statins, aspirin and angiotensin II modulators on high-sensitive protein levelsAtherosclerosis2003169155812860262
   PubMed Web of Science ®Google Scholar
• TaylorKEGiddingsJCvan den BergCWC-reactive protein-induced in vitro endothelial cell activation is an artifact caused by azide and lipopolysaccharideArterioscler Thromb Vasc Biol20052512253015802626
   PubMed Web of Science ®Google Scholar
• ThorandBLowelHSchneiderAC-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984–1998Arch Intern Med200316393912523922
   PubMed Web of Science ®Google Scholar
• TorzewskiMRistCMortensenRFC-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesisArterioscler Thromb Vasc Biol2000202094910978254
   PubMed Web of Science ®Google Scholar
• TouyzRMChenXTabetFExpression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin IICirc Res20029012051312065324
   PubMed Web of Science ®Google Scholar
• TouyzRMSavoiaCHeYIncreased inflammatory biomarkers in hypertensive type2 diabetic patients: improvement after angiotensin II type 1 receptor blockadeJ Am Soc Hypertens (JASH)2007in press
   Web of Science ®Google Scholar
• TouyzRMSchiffrinELSignal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cellsPharmacol Rev2000526397211121512
   PubMed Web of Science ®Google Scholar
• TouyzRMSchiffrinELIncreased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathwaysJ Hypertens20011912455411446714
   PubMed Web of Science ®Google Scholar
• TouyzRMSchiffrinELReactive oxygen species in vascular biology: implications in hypertensionHistochem Cell Biol20041223395215338229
   PubMed Web of Science ®Google Scholar
• TouyzRMTabetFSchiffrinELRedox-dependent signalling by angiotensin II and vascular remodelling in hypertensionClin Exp Pharmacol Physiol200330860614678251
   PubMed Web of Science ®Google Scholar
• VaughanDELazosSATongKAngiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosisJ Clin Invest19959599510017884001
   PubMed Web of Science ®Google Scholar
• VenugopalSKDevarajSJialalIMacrophage conditioned medium induces the expression of C-reactive protein in human aortic endothelial cells: potential for paracrine/autocrine effectsAm J Pathol200516612657115793305
   PubMed Web of Science ®Google Scholar
• VenugopalSHDevarajSYuhannaIDemonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cellsCirculation200210614394112234944
   PubMed Web of Science ®Google Scholar
• VermaSLiSHBadiwalaMVEndothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effect of C-reactive proteinCirculation20021051890611997273
   PubMed Web of Science ®Google Scholar
• VigoCEffect of C-reactive protein on platelet-activating factor-induced platelet aggregation and membrane stabilizationJ Biol Chem19852603418223919022
   PubMed Web of Science ®Google Scholar
• VongpatanasinWThomasGDSchwartzLC-reactive protein causes downregulation of vascular angiotensin subtype 2 receptors and systolic hypertension in miceCirculation20071151020817283257
   PubMed Web of Science ®Google Scholar
• WangCHLiSHWeiselRDC-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscleCirculation200310717839012665485
   PubMed Web of Science ®Google Scholar
• WhitworthJAChalmersJWorld health organisation-international society of hypertension (WHO/ISH) hypertension guidelinesClin Exp Hypertens2004267475215702630
   PubMed Web of Science ®Google Scholar
• YasojimaKSchwabCMcGeerEGMcGeerPLGeneration of C-reactive protein and complement components in atherosclerothic plaquesAm J Pathol200115810395111238052
   PubMed Web of Science ®Google Scholar
• YasunariKMaedaKWatanabeTComparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophyJ Am Coll Cardiol20044321162315172423
   PubMed Web of Science ®Google Scholar
• YudkinJSStehouwerCDAEmeisJJCoppackSWC-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role of cytokines originating from adipose tissue?Arterioscler Thromb Vasc Biol199919972810195925
   PubMed Web of Science ®Google Scholar
• ZoukiCBeauchampMBaronCPrevention of in vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive proteinJ Clin Invest199710052299239398
   PubMed Web of Science ®Google Scholar
• ZoukiCHaasBChanJSDLoss of pentameric symmetry of C-reactive protein is associated with promotion of neutrophil-endothelial cell adhesionJ Immunol200116753556111673552
   PubMed Web of Science ®Google Scholar
• ZwakaTPHombachVTorzewskiJC-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosisCirculation20011031194711238260
   PubMed Web of Science ®Google Scholar